What it means when bladder cancer comes back

Being told that bladder cancer has returned can bring up a flood of questions and emotions. What does recurrence mean, and what do the next steps look like? 

Bladder cancer recurrence means that cancer has returned after treatment. This may look like a new tumor forming in the bladder, cancer coming back with different characteristics, or cancer appearing in a more advanced form than before. Bladder cancer is known for having one of the highest recurrence rates among cancers, particularly in people with non-muscle-invasive bladder cancer (NMIBC). Even people with low-risk disease can see the cancer return over time, while those with high-risk or high-grade tumors face a greater likelihood of recurrence or progression. 

These statistics can feel discouraging, but they also explain why ongoing surveillance and follow-up care are such a critical part of bladder cancer management.

Recurrence vs. progression: Understanding the difference

Not all recurrences are the same. Sometimes bladder cancer comes back in a similar form to before. Other times, it becomes more aggressive, which doctors refer to as progression. Recurrence means the cancer has returned after treatment, while progression means the cancer has advanced to a higher grade, a deeper layer of the bladder wall, or another part of the body.

Evidence-based guidance powered by NCCN Guidelines®

Personalized treatment plans shaped by the latest oncology standards—tailored to your diagnosis.

Get started

View your personalized treatment plan in the Outcomes4Me app

Use your diagnosis to unlock personalized NCCN Guidelines®-aligned recommendations.

Continue in app

Dr. Elizabeth Plimack, a bladder cancer specialist at Fox Chase Cancer Center, describes bladder cancer as a disease that can change along a continuum. Cancer may move from low-grade to high-grade non-muscle-invasive disease, remain persistently non-muscle-invasive despite treatment, progress from non-muscle-invasive to muscle-invasive disease, or advance from muscle-invasive to metastatic cancer. Each of these shifts represents a different clinical situation and requires a different approach to care.

What do next steps look like after a recurrence?

When bladder cancer comes back or shows signs of progression, your care team will take another look at the disease. This often includes repeat cystoscopy, imaging, and biopsies to reassess the cancer’s stage and grade. Your doctor will also review what treatments you’ve already received and how well they worked.

Dr. Plimack notes that if a specialist is accessible, this would be a good time to consider a second opinion. She explains that it can be helpful to involve a bladder cancer expert to discuss next steps and explore whether additional options are available.

When biomarker testing matters 

When diagnosed with an advanced muscle-invasive bladder cancer, a recurrent muscle-invasive bladder cancer, or bladder cancer that has progressed and spread outside of the bladder, biomarker testing can play a critical role in guiding treatment decisions. Biomarkers are specific features of the cancer, such as genetic mutations or protein markers, that can help predict how the cancer will behave and which treatments may be most effective.

At this stage, biomarker testing can help determine whether immunotherapy, targeted therapy, or a specific clinical trial may be appropriate. As bladder cancer treatment becomes increasingly personalized, understanding the biology of the tumor can open doors to options that may not have been considered earlier in the disease course.

What do treatment options look like after bladder cancer comes back?

Treatment after recurrence depends on how the cancer has changed and where it is located. For some patients, additional bladder-directed therapies may be appropriate. For others, especially if the cancer has progressed, treatment may involve systemic therapies such as chemotherapy, immunotherapy, antibody-drug conjugates, or a combination of approaches. Surgery or radiation may also be considered in certain situations.

Dr. Plimack emphasizes that research is ongoing across all stages of bladder cancer. She explains that new therapies are actively being studied for patients whose cancer has progressed at any point along the continuum, with the goal of finding treatments that work better and are easier to tolerate.

The role of clinical trials

Clinical trials can be introduced at any point in treatment, but are often considered when a treatment stops working or when it’s time to move in a new direction. Dr. Plimack explains, “We don’t usually take someone off something that’s working to do something that’s a clinical trial.” Instead, when a treatment is no longer effective, the conversation becomes, “We could do this standard treatment, or we could do a clinical trial.” At that point, she says, doctors walk patients through the options and ask, “Here’s the trial I have here. How does that sound to you?”

She also highlights how closely cancer centers work together to expand access to trials. “Every cancer center has their own trial portfolio,” she explains, noting that specialists often communicate across institutions to help patients find appropriate trials, even if that means traveling to another center.

Questions to ask your doctor after a recurrence

If you’re told your bladder cancer has recurred or progressed, consider asking:

• Is this a recurrence or progression?
• What grade and stage is the cancer now?
• Should we do biomarker testing if it hasn’t been done already?
• What treatment options are available at this stage?
• Are clinical trials an option for me?
• Would a second opinion or specialist consultation help?

What does this mean for you?

While bladder cancer recurrence is common, it can still be an alarming thing to hear. Bladder cancer coming back doesn’t mean that options have run out. New therapies are changing the treatment landscape of bladder cancer, and platforms like Outcomes4Me can help you stay updated on the latest research.  

If you would like to connect with an Outcomes4Me oncology nurse practitioner at no charge through the Outcomes4Me app, using the “Ask Outcomes4Me” button.